Cargando…

Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy

Facial capillary malformations (CMs) become hypertrophic and nodular overtime and pose great therapeutic challenge. Here, we describe safe and effective use of tumescent‐assisted sclerotherapy (TAS) in conjunction with yellow vascular laser (577 nm) for the treatment of HFCMs. Three patients underwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Mina, Parsi, Kurosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321826/
https://www.ncbi.nlm.nih.gov/pubmed/35411941
http://dx.doi.org/10.1111/ajd.13838
_version_ 1784756143702147072
author Kang, Mina
Parsi, Kurosh
author_facet Kang, Mina
Parsi, Kurosh
author_sort Kang, Mina
collection PubMed
description Facial capillary malformations (CMs) become hypertrophic and nodular overtime and pose great therapeutic challenge. Here, we describe safe and effective use of tumescent‐assisted sclerotherapy (TAS) in conjunction with yellow vascular laser (577 nm) for the treatment of HFCMs. Three patients underwent TAS were included in the case series, and complete resolution in nodularity was achieved in all patients with TAS, with no major complications such as skin necrosis, distal embolisation, blindness and neurological adverse events such as stroke or TIA occurred in any patients.
format Online
Article
Text
id pubmed-9321826
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93218262022-07-30 Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy Kang, Mina Parsi, Kurosh Australas J Dermatol Procedural Dermatology (Direct via Eeo) Facial capillary malformations (CMs) become hypertrophic and nodular overtime and pose great therapeutic challenge. Here, we describe safe and effective use of tumescent‐assisted sclerotherapy (TAS) in conjunction with yellow vascular laser (577 nm) for the treatment of HFCMs. Three patients underwent TAS were included in the case series, and complete resolution in nodularity was achieved in all patients with TAS, with no major complications such as skin necrosis, distal embolisation, blindness and neurological adverse events such as stroke or TIA occurred in any patients. John Wiley and Sons Inc. 2022-04-12 2022-05 /pmc/articles/PMC9321826/ /pubmed/35411941 http://dx.doi.org/10.1111/ajd.13838 Text en © 2022 The Authors. Australasian Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Australasian College of Dermatologists. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Procedural Dermatology (Direct via Eeo)
Kang, Mina
Parsi, Kurosh
Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy
title Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy
title_full Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy
title_fullStr Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy
title_full_unstemmed Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy
title_short Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy
title_sort treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy
topic Procedural Dermatology (Direct via Eeo)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321826/
https://www.ncbi.nlm.nih.gov/pubmed/35411941
http://dx.doi.org/10.1111/ajd.13838
work_keys_str_mv AT kangmina treatmentoffacialhypertrophiccapillarymalformationswithtumescentassistedsclerotherapy
AT parsikurosh treatmentoffacialhypertrophiccapillarymalformationswithtumescentassistedsclerotherapy